Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Influenza Virus
    (12)
  • DNA/RNA Synthesis
    (11)
  • SARS-CoV
    (10)
  • HSV
    (9)
  • Virus Protease
    (9)
  • Antiviral
    (7)
  • HCV Protease
    (4)
  • Nucleoside Antimetabolite/Analog
    (4)
  • Antibacterial
    (3)
  • Others
    (90)
Filter
Search Result
Results for "

antiviral agent

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    177
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    3
    TargetMol | Peptide_Products
  • Dye Reagents
    2
    TargetMol | Dye_Reagents
  • PROTAC Products
    3
    TargetMol | PROTAC
  • Natural Products
    14
    TargetMol | Natural_Products
  • Isotope Products
    4
    TargetMol | Isotope_Products
  • Cell Research
    6
    TargetMol | Inhibitors_Agonists
Antiviral agent
T67904380458-45-7
Antiviral agent is thiazolidin-4-one with anti-hepatitis B activity
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Antiviral agent 38
T643962247932-38-1In house
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1, 1-Dimethylethyl)-6, 7-Dihydro-10 -(3-methoxypropoxy)-2-oxo-, (6R)- has antibacterial and antiviral activity and can be used to study Hepatitis B virus.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Antiviral agent 59
T200168
Antiviralagent 59 (compound 58) is a selective antiviral agent with drug-like properties, capable of inhibiting a broad spectrum of filoviruses. It demonstrates low off-target activity and inhibitory effects against replicative forms of Ebola virus (EBOV), Sudan virus (SUDV), and Marburg virus (MARV).
  • Inquiry Price
Size
QTY
Antiviral agent 61
T200829
Antiviralagent 61 (compound Z40) serves as an effective antiviral agent with activity against Tomato Spotted Wilt Virus (TSWV), exhibiting an EC50 value of 252 µg mL. It increases the RNA expression of Ndufb9, COX6B, 7.1.2.2, E, COX5B, Ndufs4, and SDHB, while reducing the expression of Ndufb7, Ndufa5, and G.
  • Inquiry Price
Size
QTY
Antiviral agent 62
T200850
Antiviralagent 62 (Compound 16 h) is an orally active antiviral agent that inhibits the activity of HIV with an IC50 value of 8 nM against HIV (MJ4).
  • Inquiry Price
Size
QTY
Antiviral agent 65
T2033961004319-61-2
Antiviralagent 65 (compound 9) is an antiviral agent targeting the H1N1 influenza virus, with an EC50 of 7 μg mL.
  • Inquiry Price
Size
QTY
Antiviral agent 8
T402582634704-26-8
Antiviral agent 8, surpassing lead compounds crocin-1 and crocin-2, has been identified as a potent and promising candidate with enhanced antiviral activities.
  • Inquiry Price
Size
QTY
Antiviral agent 5
T403202698336-82-0
Antiviral agent 5 is a crucial intermediate utilized in the development of antiviral agents that specifically target 3C and 3CL proteases, which includes the SARS-CoV-2 M pro enzyme.
    7-10 days
    Inquiry
    Antiviral agent 17
    T60440158227-81-7
    Antiviral agent 17 (Compound 4) is an anti-infection compound with strong antiviral effects, demonstrated by an EC50 of 0.015 μM in a human replicon assay, and effective against murine norovirus. It has potential applications in studying infectious and malignant diseases[1].
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 18
    T606732170185-97-2
    Antiviral agent 18 (Compound 5) demonstrates significant antiviral activity against murine norovirus and holds potential for research in infectious and malignant diseases [1].
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 10
    T61856312615-62-6
    Antiviral agent 10 effectively inhibits the respiratory syncytial virus (RSV) [1], serving as a potent anti-viral compound.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 14
    T623092755814-80-1
    Antiviral agent 14 is an antiviral compound that inhibits tobacco mosaic virus (TMV) with an EC50 of 135.5 μg mL and cucumber mosaic virus (CMV) with an EC50 of 178.6 μg mL.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 15
    T62780
    Antiviral agent 15 (Compound 15f) is a Clofazimine derivative with antiviral activity, inhibiting the rabies virus (EC50: 1.45 μM) and pseudotyped SARS-CoV-2 (EC50: 14.6 μM).
    • Inquiry Price
    10-14 weeks
    Size
    QTY
    Antiviral agent 19
    T631251807887-16-6
    Antiviral agent 19 (Compound 3) is a selective inhibitor of the Zika virus (EC50: 1.3 μM) with low cytotoxicity.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 6
    T63666
    Antiviral agent 6 showed excellent anti-TSWV effects in vivo (EC50: 188 mg L).
    • Inquiry Price
    10-14 weeks
    Size
    QTY
    Antiviral agent 7
    T63921
    Antiviral agent 7 is a peptide-based coating that effectively eliminates viruses.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
    Antiviral agent 20
    T641662407570-07-2
    Antiviral agent 20 (Compound 17b) is a selective inhibitor of Zika virus (EC50: 4.5 μM) with low cytotoxicity.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 23
    T7256235940-03-5
    Antiviral Agent 23, an effective inhibitor of enterovirus 71 (EV71) with an EC50 value of 94 nM, also exhibits potent suppression of METTL3 METTL14 activity. This compound is employed in the research of infections.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 9
    T72593
    Antiviral agent 9 exhibits potent efficacy against HIV-1 with an EC50 value of 0.006 nM, indicating extremely low concentrations are sufficient to inhibit the virus. Additionally, it demonstrates a selectivity index (SI) nearly 300 times higher than that of tenofovir alafenamide fumarate (TAF), outlining its superior selectivity and potential safety profile.
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 25
    T750652761367-25-1
    Antiviral agent 25 (compound 6g), a novel non-peptide analog covalent inhibitor of SARS-CoV-2 3CL pro, exhibits robust inhibitory activity against both SARS-CoV-2 3CL pro and SARS-CoV-2 PL pro, with IC50 values of 0.118 µM and 0.448 µM, respectively. Furthermore, it demonstrates significant antiviral effects against SARS-CoV-2, achieving an EC50 value of 7.249 µM [1].
    • Inquiry Price
    3-6 months
    Size
    QTY
    antiviral agent 34
    T77632945152-88-5
    Antiviral agent 34 is an orally available, potent antiviral compound that inhibits influenza A and B viruses.Antiviral agent 34 inhibits the proliferation of influenza viruses by modulating RNA polymerase.Antiviral agent 34 is used in the study of viral infections.
    • Inquiry Price
    8-10 weeks
    Size
    QTY
    Antiviral agent 30
    T79128381731-49-3
    Antiviral Agent 30 (Example 118) is an active compound against HCV and RSV with an inhibitory concentration (IC 50) of greater than 25μM [1].
    • Inquiry Price
    6-8 weeks
    Size
    QTY
    Antiviral agent 36
    T79334
    Antiviral agent 36 (compound 27), a potent inhibitor of both dengue (DENV) and Zika (ZIKV) viruses, demonstrates replication inhibition with EC50 values of 100 nM for ZIKV-FLR, 90 nM for ZIKV-HN16, 210 nM for DENV-2, and 120 nM for DENV-3 [1].
    • Inquiry Price
    Size
    QTY
    Antiviral agent 35
    T795672760972-52-7
    Antiviral agent 35 (compound 4d) is a potent oral inhibitor of the influenza virus, targeting early stages of viral replication. It suppresses influenza-induced ROS accumulation, autophagy, apoptosis, and the inflammatory response mediated by the RIG-1 pathway in a mouse model of pulmonary infection. Its cytotoxicity is minimal in MDCK cells, with a CC50 greater than 800 μM, and it has anti-H1N1 (A Weiss 43) activity with an EC50 of 2.28 μM [1].
    • Inquiry Price
    8-10 weeks
    Size
    QTY